Molecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptor.
The human β2-adrenergic receptor (β2AR), a member of the G-protein coupled receptor (GPCR) family, is expressed in bronchial smooth muscle cells. Upon activation by agonists, β2AR causes bronchodilation and relief in asthma patients. The N-terminal polymorphism of β2AR at the 16th position, Arg16Gly...
Main Authors: | Ganesh Shahane, Chirag Parsania, Durba Sengupta, Manali Joshi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-12-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1004006 |
Similar Items
-
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
by: Christopher M O'Connor, et al.
Published: (2012-01-01) -
ABCB1 variant provides important leads for pharmacogenetics of epilepsy
by: M N Phani, et al.
Published: (2014-01-01) -
Functional Characterization of the Obesity-Linked Variant of the β<sub>3</sub>-Adrenergic Receptor
by: Esraa Haji, et al.
Published: (2021-05-01) -
Human β<sub>1</sub>-adrenergic receptor:biosynthesis, processing and the carboxyl-terminal polymorphism
by: Hakalahti, A. (Anna)
Published: (2011) -
β1-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes
by: Misun Park, et al.
Published: (2017-08-01)